Tate & Lyle PLC – Sucralose update

14 Feb 2006

| Filed in:

Tate & Lyle has become aware of the re-appearance of a low-calorie tabletop sweetener product branded as 'Altern' in a small number of Wal*Mart stores in the US. Altern is described as containing sucralose. Tate & Lyle has analysed samples of this product and believes it to contain an active ingredient of Chinese origin. Work is being carried out to determine if this ingredient meets the stringent US Food and Drug Administration specifications and / or infringes on Tate & Lyle’s intellectual property. This ingredient cannot be branded as SPLENDA® Brand Sweetener; SPLENDA® is the leading US low-calorie tabletop sweetener brand. The quantity of sucralose required for a single table-top product such as Altern is extremely small and the supply of sucralose to the table-top sector is a minor part of Tate & Lyle’s SPLENDA® Sucralose ingredients business. Tate & Lyle does not expect the launch of this product, even were it to be on a national scale, to have any material effect on the results of its sucralose division and is making this statement in recognition of the high level of investor interest in sucralose.
END SPLENDA® and the SPLENDA® logo are trademarks of McNeil Nutritionals, LLC

Click here for our press image gallery

About Tate & Lyle PLC:

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.

Through our leading expertise in sweetening, mouthfeel and fortiﬁcation, we develop ingredients and solutions which reduce sugar, calories and fat, add ﬁbre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube

Previous press release Tate & Lyle PLC - Trading Update

View all Press releases

Next press release Tate & Lyle PLC invests in a Sugar plant in Israel